Funding for this research was provided by:
Scientific Research Project of Shanghai Municipal Health and Family Planning Commission (20184Y0094)
Shanghai Municipal Health and Family Planning Commission Three-year Action Plan-Dominant Disease Cultivation Project ((ZY(2018-2020) -ZYBZ-32))
the National Natural Science Foundation of China (81804021)
Innovative Research Group Project of the National Natural Science Foundation of China (81774271)
Shanghai Science and Technology Commission guided projects (17407931500)
Received: 24 December 2020
Accepted: 19 September 2021
First Online: 18 October 2021
: The study was approved by the research ethics committee of the Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine (identifier: 201809-01). All procedures performed in the studies involving human participants were carried out in accordance with the ethical standards of the institutional and/or national research ethics committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. A written informed consent would be obtained from each participant and would be provided to the patients for signature prior to the study enrollment. To encourage adherence to the treatment, all patients would receive the study drug and laboratory tests for free during the entire observational period. In order to protect the privacy of patients, the original materials are also stored in the hospital and cannot be accessed without the consent of the ethics committee. Data publication will also hide the patient's name.
: Not applicable.
: The authors declare that they have no competing interests.